Study | Patients enrolled/tested | Penicillin skin testing (PST) results | Use of beta-lactam antibiotics as a result of PST | Study details/comments |
Arroliga (2003)[1] | 100/96 |
|
| Intensive care unit patients. |
Wall (2004)[2] | 26/23 |
|
| PST performed by allergist-trained pharmacist. Almost all patients (n = 22) were referred for evaluation by infectious diseases consultation. |
Park (2011)[3] | 503/71 |
|
| Pharmacist screened all patients and recommended allergy consultation for PST in select patients. |
Rimawi (2013)[4] | 482/146 |
|
| Most inclusive study with about one-third of inpatients with penicillin allergy included in study. Beta-lactam antibiotics used were predominantly broad-spectrum, including piperacillin-tazobactam (n = 42), ceftriaxone (n = 27), and cefepime (n = 23). In this study, 217 patients were excluded because of uncertain allergy history, but were PST-eligible. |
King (2016)[5] | NA/50 |
|
| Patients were highly selected, including screened for skin test eligibility and already prescribed a broad-spectrum antibiotic. |
Heil (2016)[6] | 90/76 |
|
| Skin testing service run by infectious diseases fellows and patients were highly selected through antibiotic stewardship team referral, infectious diseases consultation service, or the direct request of hospital team. |
Chen (2016)[7] | 252/228 PST was completed in 19% of penicillin-allergic inpatients |
|
| Electronic health record screened 1203 patients with penicillin allergy. Pharmacist prioritized based on patient length of stay, antibiotic therapy, and comorbidities. |
Blumenthal (2017)[8] | 278/42 Included all internal medicine patients at a tertiary care academic medical center with penicillin allergy being treated for an infection |
|
| Only study that provides insight into policy impact of proactive PST with adjusted analyses. |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟